Variables Associated With Human Papillomavirus (HPV) Vaccine Acceptance by Men

References

1. ↵
   Villa LL, Costa RLR, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) L1 virus-like particle vaccine in young women: a randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005; 6: 271–78.

   OpenUrlCrossRefPubMedWeb of Science
2. The FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356: 1915–27.

   OpenUrlCrossRefPubMedWeb of Science
3. The FUTURE II Study Group. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3 and adenocarcinoma in situ. A combined analysis of four randomized clinical trials. Lancet 2007; 369: 1861–8.

   OpenUrlCrossRefPubMedWeb of Science
4. Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007; 356: 1928–43.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   Nielson CM, Flores R, Harris RB, et al. Human papillomavirus prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol Biomarkers Prev 2007; 16: 1107–14.

   OpenUrlAbstract/FREE Full Text
6. ↵
   Wiatrak BJ, Wiatrak DW, Broker TR, Lewis L. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope 2004; 114: 1–23.

   OpenUrlPubMedWeb of Science
7. ↵
   Maloney EM, Unger ER, Tucker RA, et al. Longitudinal measures of human papillomavirus 6 and 11 viral loads and antibody response in children with recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 2006; 132: 711–5.

   OpenUrlCrossRefPubMed
8. ↵
   Abramowitz L, Benabderrahmane D, Ravaud P, et al. Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors. AIDS 2007; 21: 1457–65.

   OpenUrlCrossRefPubMedWeb of Science
9. Cupp MR, Malek RS, Goellner JR, Smith TF, Espy MJ. The detection of human papillomavirus deoxyribonucleic acid in intraepithelial, in situ, verrucous and invasive carcinoma of the penis. J Urol 1995; 154: 1024–9.

   OpenUrlCrossRefPubMedWeb of Science
10. Gregoire L, Cubilla AL, Reuter VE, Hass GP, Lancaster WD. Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. J Natl Cancer Inst 1995; 87: 1705–9.

    OpenUrlAbstract/FREE Full Text
11. Malek RS, Goellner JR, Smith TF, Espy MJ, Cupp MR. Human papillomavirus infection and intraepithelial, in situ, and invasive carcinoma of the penis. Urol 1993; 42: 159–70.

    OpenUrlPubMed
12. Palefsky JM, Holly EA, Ralston ML, Jay N, Berry JM, Darragh TM. High incidence of anal high-grade squamous intraepithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS 1998; 12: 495–503.

    OpenUrlCrossRefPubMedWeb of Science
13. Frish M, Glimelius B, van den Brule AJ, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337: 1350–8.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 2005; 32: S59–66.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944–56.

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    Ferris DG, Waller JL, Owen A, Smith J. HPV vaccine acceptance among mid-adult women. J Am Bd Fam Med 2008; 21: 31–7.

    OpenUrl
17. ↵
    Ferris DG, Waller JL, Owen A, Smith J. Mid adult women's attitudes about receiving the prophylactic human papillomavirus vaccine. J Lower Genital Tract Dis 2007; 11: 166–72.

    OpenUrl
18. ↵
    Ferris DG, Waller JL, Miller J, et al. Men's attitudes toward receiving the HPV vaccine. J Lower Genital Tract Dis 2008; 12: 276–81.

    OpenUrl
19. ↵
    Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis 2006; 194: 1044–57.

    OpenUrlAbstract/FREE Full Text
20. ↵
    Wiley DJ, Wiesmeier E, Masongsong E, et al. Smokers at higher risk for undetected antibody for oncogenic human papillomavirus type 16 infection. Cancer Epidemiol Biomarkers Prev 2006; 15: 915–20.

    OpenUrlAbstract/FREE Full Text
21. ↵
    McIntyre-Seltman K, Castle PE, Guido R, Schiffman M, Wheeler CM, ALTS Group. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers Prev 2005; 14: 1165–70.

    OpenUrlAbstract/FREE Full Text
22. ↵
    Ferris DG, Hainer BL, Pfenninger JL, Zuber TJ. See and treat electrosurgical loop excision of the cervical transformation zone. J Fam Pract 1996; 42: 253–7.

    OpenUrlPubMed
23. ↵
    Davis K, Dickman ED, Ferris DG, Dias JK. Human papillomavirus vaccine acceptability among parents of 10 to 15 year old adolescents. J Low Genit Tract Dis 2004; 8: 188–94.

    OpenUrlCrossRefPubMed